Advanced search×

Vascular Pharmacology

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Rcgp, Gale, Sciencedirect, and Ingenta

  1. Cyclooxygenase Inhibition and Rosuvastatin-induced Vascular Protection in the Setting of Ischemia Reperfusion: A Human in vivo Study

    Vascular Pharmacology (2015)

    The 3-hydroxy-3-methyglutaryl coenzyme A (HMG Co-A) reductase inhibitors have preconditioning effects involving up-regulation of cyclooxygenase (COX)-2. We investigated the effect of selective and non-selective COX inhibition on rosuvastatin-mediated protection against ischemia reperfu...
  2. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 64:IFC (2015)

  3. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(3):IFC (2014)

  4. Differential mechanisms for insulin-induced relaxations in mouse posterior tibial arteries and main mesenteric arteries

    Vascular Pharmacology 63(3):173 (2014) PMID 25446161

    The characteristics of endothelium-dependent relaxations in response to insulin and acetylcholine (ACh) in the mouse posterior tibial artery (PTA) were studied on wire myograph, and compared to those in the mouse main mesenteric artery (MMA). Insulin-induced relaxation in PTA was rever...
  5. Vascular effects of the Mediterranean diet—Part II: Role of omega-3 fatty acids and olive oil polyphenols

    Vascular Pharmacology 63(3):127 (2014) PMID 25446163

    The lower occurrence of cardiovascular disease and cancer in populations around the Mediterranean basin as detected in the 1950s was correctly attributed to the peculiar dietary habits of those populations. Essentially, until the mid-20th century, typical Mediterranean diets were rich ...
  6. The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension

    Vascular Pharmacology 63(3):114 (2014) PMID 25446166

    Pulmonary arterial hypertension (PAH) is a fatal condition driven by a progressive remodelling of the small pulmonary arteries through sustained vasoconstriction, and vascular cell proliferation. This process causes a substantial reduction in luminal area increasing pulmonary vascular ...
  7. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(2):IFC (2014)

  8. Activation of Nrf2 by dimethyl fumarate improves vascular calcification

    Vascular Pharmacology 63(1):29 (2014) PMID 25135648

    Dimethyl fumarate (DMF) has several pharmacological benefits including immunomodulation and prevention of fibrosis, which are dependent on the NF-E2-related factor 2 (Nrf2) antioxidant pathways. Therefore, we hypothesized that DMF could attenuate vascular calcification via Nrf2 activat...
  9. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 63(1):e1 (2014)

  10. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(1):IFC (2014)